While the increased risk of the PRNP M129 allele on APOE ε4 carriers was mainly associated with individuals with earlier AD onset; the APOE ε4 allele risk on PRNP codon 129 homozygous was mainly patent in the population with later sCJD onset. This evidence concerns the gene APOE and Alzheimer disease.